CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia

Brazilian Journal of Infectious Diseases

Volumn 16, Issue 5, 2012, Pages 420-425

  Martinez, Pedro ^a   Garzón, Denisse ^a   Mattar, Salim ^a  

^a UNIVERSIDAD DE CÓRDOBA   (Colombia)

Author keywords

Colombia; Community acquired UTIs; CTX M; E. coli; ESBL; K. pneumonia

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; TETRACYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; BETA LACTAMASE CMY 2 GENE; BETA LACTAMASE CTX M 1 GENE; BETA LACTAMASE CTX M 2 GENE; BETA LACTAMASE CTX M 8 GENE; BETA LACTAMASE CTX M 9 GENE; BETA LACTAMASE PER 2 GENE; BETA LACTAMASE SHV GENE; BETA LACTAMASE TEM GENE; COLOMBIA; COMMUNITY ACQUIRED URINARY TRACT INFECTION; DISK DIFFUSION; ENZYME SYNTHESIS; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GENETIC ASSOCIATION; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; SCREENING TEST; STRAIN IDENTIFICATION; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; COLOMBIA; COMMUNITY-ACQUIRED INFECTIONS; DISK DIFFUSION ANTIMICROBIAL TESTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS;

EID: 84866842669     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.05.001     Document Type: Article

References (33)

1. Villegas M.V., Correa A., Perez F., et al. Prevalence and characterization of extended-spectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diag Microbiol Infect Dis 2004, 49:217-222.
2. Celik A.D., Yulugkural Z., Kuloglu F., et al. CTX-M type extended spectrum β-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey. J Microbiol Immunol Infect 2010, 43:163-167.
3. Ambler R.P. The structure of beta-lactamases. Phil Trans R Soc B 1980, 289:321-331.
4. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004, 48:1-14.
5. Apisarnthanarak A., Kiratisin P., Mundy L. Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum β-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes. Infect Control Hosp Epidemiol 2008, 29:1026-1034.
6. Nicolas-Chanoine M., Blanco J., Leflon-Guibout V., et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008, 61:273-281.
7. Ben-Ami R., Schwaber M.J., Navon-Venezia S., et al. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006, 42:925-934.
8. Guidoni E., Berezin E., Nigro S., et al. Antibiotic resistance patterns of pediatric community-acquired urinary infections. Braz J Infect Dis 2008, 12:321-323.
9. Farmer J. Enterobacteriaceae: introduction and identification. Manual of clinical microbiology 1999, 442-458. American Society of Microbiology, Washington DC. 7th ed. P. Murray, E. Baron, M. Pfaller, F. Tenover, R. Yolken (Eds.).
10. Performance standards for antimicrobial susceptibility testing; fourteenth informational supplement. CLSI document M100-S21 2011, Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute (CLSI), Wayne, PA.
11. Carter M.W., Oakton K.J., Warner M., Livermore D.M. Detection of extended-spectrum β-lactamases in Klebsiellae with the oxoid combination disk method. J Clin Microbiol 2000, 38:4228-4232.
12. Dubois V., Arpin C., Noury P., et al. Prolonged outbreak of infection due to TEM-21-producing strains of Pseudomonas aeruginosa and Enterobacteria in a nursing home. J Clin Microbiol 2005, 43:4129-4138.
13. Silva J., Gatica R., Aguilar C., et al. Outbreak of infection with extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Mexican hospital. J Clin Microbiol 2001, 39:3193-3196.
14. Villegas M.V., Correa A., Perez F., et al. CTX-M-12 β-lactamase in a Klebsiella pneumoniae clinical isolate in Colombia. Antimicrob Agents Chemother 2004, 48:629-631.
15. Paterson D.L., Hujer K.M., Hujer A.M., et al. Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases. Antimicrob Agents Chemother 2003, 47:3554-3560.
16. Bauernfeind A., Stemplinger I., Jungwirth R., et al. Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase. Antimicrob Agents Chemother 1996, 40:616-620.
17. Martinez P., Espinal P., Máttar S. Epidemiología molecular de Pseudomonas aeruginosa resistente a b- lactámicos de amplio espectro en el Hospital San Jerónimo de Montería. Infectio 2007, 11:6-15.
18. Demirdag K., Hosoglu S. Epidemiology and risk factors for ESBL-producing Klebsiella pneumoniae: a case control study. J Infect Dev Ctries 2010, 4:717-722.
19. Villegas M.V., Blanco M.G., Sifuentes-Osornio J., Rossi F. Increasing prevalence of extended-spectrum-betalactamase among Gram-negative bacilli in Latin America: 2008 update from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Braz J Infect Dis 2011, 15:34-39.
20. Schito G.C., Naber K.G., Botto H., et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Inter J Antimicrob Agents 2009, 34:407-413.
21. Falagas M.E., Grammatikos A.P., Michalopoulos A. Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev Anti Infect Ther 2008, 6:593-600.
22. Pitout J., Laupland K. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
23. Villegas M.V., Kattan J.N., Quinteros M.G., Casellas J.M. Prevalence of extended-spectrum beta-lactamases in South America. Clin Microbiol Infect 2008, 14(Suppl. 1):154-158.
24. Ruiz S.J., Montealegre M.C., Ruiz-Garbajosa P., et al. First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America. J Clin Microbiol 2011, 49:1993-1996.
25. Keynan Y., Rubinstein E. The changing face of Klebsiella pneumoniae infections in the community. Inter J Antimicrob Agents 2007, 30:385-389.
26. Motta R.N., Oliveira M.M., Magalhães P.S., et al. Plasmid-mediated extended-spectrum b-lactamase-producing strains of Enterobacteriaceae isolated from diabetes foot infections in a Brazilian diabetic center. Braz J Infect Dis 2003, 7:129-134.
27. Haldorsen B., Aasnaes B., Dahl K., et al. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC. J Antimicrob Chemother 2008, 62:694-702.
28. Navarro F., Calvo J., Cantón R., Fernández-Cuenca F., Mirelis B. Detección fenotípica de mecanismos de resistencia en microorganismos gramnegativos. Enferm Infecc Microbiol Clín 2011, 29:524-534.
29. Martínez P., Máttar S. Emergencia de la resistencia antibiótica debida a las β-lactamasas de espectro extendido (BLEE): detección, impacto clínico y epidemiología. Infectio 2007, 11:23-35.
30. Leverstein-van Hall M.A., M.Blok H.E., Donders A.R., Paauw A., Fluit A.C., Verhoef J. Multidrug resistance among Enterobacteriaceae Is strongly associated with the presence of integrons and is independent of species or isolate origin. J Infect Dis 2003, 187:251-259.
31. Paterson D.L., Mulazimoglu L., Casellas J.M., et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000, 30:473-478.
32. Akpaka P.E., Swanston W.H. Phenotypic detection and occurrence of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli at a tertiary hospital in Trinidad & Tobago. Braz J Infect Dis 2008, 12:516-520.
33. Serefhanoglu K., Turan H., Timurkaynak F., Arslan H. Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance. Braz J Infect Dis 2009, 13:403-407.